Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of April 2026, with a report date of April 10, 2026. The document serves as a transaction notification detailing share acquisitions by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) under the Company's Share Reward Plan.
Key Financial Metrics
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively reports on specific share transactions.
| Instrument | Transaction Date | Price per Share | Total Volume | Exchange |
|---|---|---|---|---|
| Ordinary Shares (31½ pence each) | April 9, 2026 | £21.3387 | 246 shares | London Stock Exchange (XLON) |
| Ordinary Shares (31½ pence each) | April 9, 2026 | £21.5039 | 1,214 shares | London Stock Exchange (XLON) |
Note: Two distinct transaction prices were recorded on the same date for different participants. The total volume across all reported transactions is 1,460 shares.
Material Changes
The filing does not contain comparative financial data or material changes in the company's operational or financial status versus prior periods. The only reported activity is the routine acquisition of shares via dividend reinvestment.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. The transactions are described as acquisitions following the reinvestment of dividends paid to shareholders on April 9, 2026, for shares held through the Company's Share Reward Plan.
Investor Verification Checklist
- Verify the total number of shares acquired by PDMRs and PCAs (1,460 shares) against the company's internal share plan records.
- Confirm the two distinct execution prices (£21.3387 and £21.5039) on April 9, 2026, to understand intraday volatility or settlement timing.
- Review the specific roles of the individuals involved (e.g., CEO, President, SVP) to assess insider confidence levels.
- Check the company's latest Form 20-F for comprehensive financial performance data, as this Form 6-K does not include it.